Rubella hepatitis

At present, vaccines are available for several serious viral infections, including polio, smallpox, rabies, measles, mumps, rubella, hepatitis A and B, and influenza. In some situations, vaccination against certain viral infections is routine. For instance, schoolchildren must periodically show evidence of polio, measles, and other vaccinations according to state and local laws. In other cases, vaccines are administered prior to potential exposure to the virus or in high-risk groups. Influenza vaccinations, for example, are often administered to elderly and debilitated patients during seasonal influenza outbreaks.75,109... 

Guillain-Barrb syndrome was particularly associated with swine flu vaccine in 1976. It has rarely been associated with other vaccines — tetanus toxoid, BCG, rabies, smallpox, mumps, rubella, hepatitis B, diphtheria, and polio (Wraith et al., 2003). 

Rubella Vaccine, Live Mumps Vaccine, rDNA Hepatitis B Vaccine, Oral Poliovirus Vaccine, Erythropoietin, and Factor IX etcetera. 

There are several combination vaccines available in the United States. One of the most popular pediatric combinations is Pediarix a combination of diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, and hepatitis B vaccines. ComVax is a combination of Haemophilus influenzae type b and hepatitis B vaccines. The most recent combination is ProQuad which contains measles, mumps, rubella, and varicella vaccines. The only combination available for adults is Twinrix which has hepatitis A and hepatitis B vaccines. 

Following hematopoietic stem cell transplantation the patient will need virtually all routine vaccines to be administered again however, the patient will not be able to mount an adequate response for 6 to 12 months post-transplant. Diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, hepatitis B, pneumococcal, and inactivated poliovirus should be given at 12,14, and 24 months post-hematopoietic stem cell transplantation. Inactivated influenza vaccine should be given yearly, starting 6 months after transplant. Measles, mumps and rubella can be given 2 years after transplant and varicella vaccine is contraindicated.16... 

Most health care workers are at risk for exposure to many diseases in the normal course of their work. Additionally, health care workers may transmit vaccine-preventable diseases to their patients. At the time of employment and on a regular basis, health care workers should be screened for immunity to measles, rubella, and varicella if found to be non-immune, the measles, mumps, and rubella, and varicella vaccines should be administered. The hepatitis B series should be given if not already completed. Tetanus should be updated and given every 10 years. Health care personnel in hospitals and ambulatory settings with direct patient contact should receive Tdap if not already received an interval as short as 2 years from the last tetanus-containing vaccine should be used. Priority for receiving Tdap should be given to personnel with direct contact with infants less than 12 months of age. 

Suggested Alternatives for Differential Diagnosis Dengue, measles, Rocky Mountain spotted fever, rubella, tick bite fever, epidemic typhus, Q fever, typhoid, malaria, trypanosomiasis, hepatitis, infectious mononucleosis, herpes, and influenza. 

Viral vaccines are cultivated on inanimate media. Some examples include hepatitis b vaccine, influenza virus vaccine, measles virus vaccine, rabies vaccine, rubella vaccine, and yellow fever vaccine. The viral vaccines are available as lyophilized powder for reconstitution, or suspension for injections,... 

Tinea pedis is a fungal infection commonly known as athlete s foot. Chickenpox is a childhood infection caused by the herpes zoster virus. Hepatitis is a viral infection of the liver. Mumps is a viral infection characterised by bilateral or unilateral inflammation of the salivary glands. Rubella (German measles) is caused by the rubella virus. 

Normal immunoglobulin preparations are purified from pooled material obtained from 1000 or more donors. They will generally contain antibodies against diphtheria, measles, poliomyelitis, hepatitis A, rubella and varicella. Normal immunoglobulin may, therefore, be used to provide passive immunization against these diseases. 

Three basic approaches are used to control viral diseases vaccination, antiviral chemotherapy, and stimulation of host resistance mechanisms. Vaccination has been used successfully to prevent measles, rubella, mumps, poliomyelitis, yellow fever, smallpox, chickenpox, and hepatitis B. Unfortunately, the usefulness of vaccines appears to be limited when many stereotypes are involved (e.g., rhinoviruses, HIV). Furthermore, vaccines have little or no use once the infection has been established because they cannot prevent the spread of active infections within the host. Passive immunization with human immune globulin, equine antiserum, or antiserum from vaccinated humans can be used to assist the body s own defense mechanisms. Intramuscular preparations of immune globulin may be used to prevent infection following viral exposure and as replacement therapy in individuals with antibody deficiencies. Peak plasma concentrations of intramuscular immune globulins occur in about 2 days. In contrast, intravenously administered immune globulin provides immediate passive immunity. 

Viruses have no cell wall and made up of nucleic acid core enclosed in a protein coat which consists of identical subunits. Viruses are of two types, DNA (deoxyribonucleic acid) viruses and RNA (ribonucleic acid) viruses. DNA viruses are herpes simplex, small pox, hepatitis B, varicellazoster etc. and RNA viruses are rabies, measles, dengue, rubella, yellow fever, poliomyelitis and HIV etc. 

Given prophylactically or soon after exposure to hepatitis A given to prevent or modify measles (Rubeola), Varicella (Zoster), Rubella, and immunoglobulin deficiency... 

Abbreviations Hib-HBsAg, Haemophilus influenzae type B-hepatitis B surface antigen Hep A, hepatitis A DTaP, diphtheria-tetanus-acellular pertusis vaccine MMR, mumps, measles, rubella. 

Vaccines in diis category protect children and adults from polio, diphtheria, tetanus, pertussis (whooping cough), measles (rubeola), mumps, rubella (German measles), hepatitis B, and hacmophilus disease (meningitis, epiglotitis). 

Test results, standards to be met. The residual moisture and other volatile substances shall not exceed 1.0 percent except that, (i) they. shall not exceed 1.5 percent for BCG Vaccine, (ii) they shall not exceed 2.0 percent for Measles Vims Vaccine Live, Measles Live and Smallpox Vaccine, Rubella Vims Vaccine Live, and Antihemophilic Factor (Human) (iii) they shall not exceed 3.0 percent for Thrombin and Streptokinase, and (iv) they shall not exceed 4.5 percent for Antibody to Hepatitis B Surface Antigen for the Reverse Passive Hemaglutination Test. ... 

Virus infections Acute viral hepatitis (HAV, HEV, HCV) is accompanied by cholestasis in 5-20% of cases. (63) The frequency differs from country to country. It is most prevalent in those with a severe form of the disease, elderly people and women. Cholestasis is also common in viral infections with concomitant hepatitis, especially due to CMV, Coxsackie virus, rubella virus, HSV (types I, II, IV), HIV, REO virus (type III), parvovirus (type B 19), and ECHO virus (types 9, 11, 14, 19). 

Aral, M., Wada, N., Marnyama, K., Nomiyama, T., Tanaka, S., Okazaki, I. Acute hepatitis in an adult with acquired rubella infection. J. Gastroenterol. 1995 30 539—542... 

Virus infections Viral cholangiopathy, sometimes with concomitant destruction of the intrahepatic bile ducts, has been reported to derive from several species of viruses, e.g. HIV, cytomegaly, rotaviruses, respiratory syncitial virus (RS), hepatitis C, congenital rubella and reovirus 1 Bacteria may, however, also be the cause of disease, as is the case with congenital syphilis. 

Vaccines [30-35] Various vaccines have been studied, including hepatitis A and B, yellow fever, influenza, measles, mumps, rubella, diphtheria, tetanus, typhoid, and tuberculosis... 

Data from the VAERS on arthritic reactions (arthralgia, arthrosis, arthritis, and joint disease) after rubella immunization during 1991-98 have been analysed (Table 3) (122). Hepatitis A vaccine-associated arthritic reactions reported to VAERS during 1997-98 were used as controls. The analysis confirmed that rubella vaccine is associated with a large number of arthritic reactions. Among the female subjects given rubella vaccine, these reactions occurred primarily in the adult women. The incidence of arthritic reactions was 126 per million rubella immunizations, whereas the hepatitis A vaccine adult control group had an incidence rate of 3.2 per million immunizations. 

In the USA, the National Childhood Vaccine Injury Act of 1986 established the National Vaccine Injury Compensation Program as a federal no-fault compensation system for individuals who may have been injured by specific vaccines. This compensation program relies on a Vaccine Injury Table that lists the vaccines that are covered by the program, as well as injuries, disabilities, illnesses, and conditions (including death) for which compensation may be awarded. To better reflect current scientific knowledge about vaccine injuries, the Vaccine Injury Table was revised in 1995 and has been subsequently further modified. The latest modification, which became effective on December 1, 2004, is shown in Table 7. This revision took into account a review of the literature on specific adverse consequences of pertussis and rubella vaccines performed and published by the lOM (SED-12, 817) (SED-12, 825). In addition to the seven vaccines (diphtheria, pertussis, tetanus, measles, mumps, rubella, and poliomyelitis) included in the first Vaccine Injury Table, the 1997 revision includes hepatitis B, Hemophilus influenzae type b, and Varicella vaccines, as well as any future licensed vaccine recommended by the Advisory Committee on Immunization Practices (ACIP) for routine administration to children (38). 

Human diploid cell lines have been utilized classically as in vitro hosts for the propagation of polio, mumps, rubella, cytomegalovirus, varicella-zoster, rabies, hepatitis A, respiratory syncytial virus, parainfluenza and many other viruses. Other uses in the biotechnology industry include large-scale cultivation for the production of various cellular products, such as human interferon beta. 

---